Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Lidocaine hydrochloride anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

77 API Suppliers, 13 USDMF, 10 CEP/COS, 3 JDMF, 7 EU WC, 14 KDMF, 27 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

FINISHED DOSAGE FORMULATIONS

559 FDF Dossiers, 228 FDA Orange Book, 208 Europe, 66 Canada, 17 South Africa, 40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%, INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;SPINAL - 5%, JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 6 Rochem International Inc, 12 SPI Pharma, 18 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 18 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Capital Farma, 15 Kirsch Pharma, 1 ACG Worldwide, 22 Actylis, 3 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 43 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 5 CD Formulation, 1 Clariant, 17 Corel Pharma Chem, 3 Doshion Polyscience, 2 Esteem Industries, 5 Finar, 13 Gangwal Chemicals, 3 Ideal Cures, 2 Ingredion Pharma Solutions, 10 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 9 Lubrizol Life Science Health, 9 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 25 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 2 Symrise, 3 The Dow Chemical Company, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

79 Topical, 67 Solubilizers, 58 Thickeners and Stabilizers, 48 Coating Systems & Additives, 45 Parenteral, 36 Fillers, Diluents & Binders, 35 Emulsifying Agents, 29 Controlled & Modified Release, 25 Surfactant & Foaming Agents, 25 Film Formers & Plasticizers, 21 Rheology Modifiers, 19 Taste Masking, 18 Granulation, 17 Direct Compression, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 10 API Stability Enhancers, 8 Chewable & Orodispersible Aids, 7 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 61 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 41 Regulatory FDF Prices

MARKET PLACE

56 APIs, 15 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
27/09/2025	Swati Spentose	India	Daeshin Pharmaceutical Co., Ltd.	20200108-210-J-409	lidocaine hydrochloride	2020-01-08	Swati Spentose Private Limited (Unit-I)	India	Plot No. - A-1/2102, 2103 & A-2/2120, Phase III, GIDC, Vapi - 396 195, Dist. - Valsad, Gujarat State, INDIA.
27/09/2025	Delta Synthetic Co. Ltd	Taiwan	SPC Co., Ltd.	20210309-210-J-704(8)	lidocaine hydrochloride	2022-06-20	Delta Synthetic Co., Ltd.	Taiwan	15, Minsheng St., Tucheng Dist., New Taipei City 23679, Taiwan, ROC

Lidocaine Hydrochloride Anhydrous

Lidocaine hydrochloride anhydrous

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

77 API Suppliers

13 USDMF

10 CEP/COS

3 JDMF

7 EU WC

14 KDMF

27 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

22 Drugs in Development

FINISHED DOSAGE FORMULATIONS

559 FDF Dossiers

228 FDA Orange Book

208 Europe

66 Canada

17 South Africa

40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%

INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.005MG/ML;0.5%

INJECTABLE;INJECTION - 0.005MG/ML;1%

INJECTABLE;INJECTION - 0.005MG/ML;1.5%

INJECTABLE;INJECTION - 0.005MG/ML;2%

INJECTABLE;INJECTION - 0.01MG/ML;1%

INJECTABLE;INJECTION - 0.01MG/ML;2%

INJECTABLE;INJECTION - 0.02MG/ML;2%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 1.5%

INJECTABLE;INJECTION - 2%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 2%

INJECTABLE;INJECTION - 1%

INJECTABLE;SPINAL - 5%

JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Evonik

6 Rochem International Inc

12 SPI Pharma

18 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

1 Boai NKY Pharmaceuticals Ltd

2 Gangwal Healthcare

18 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Capital Farma

15 Kirsch Pharma

1 ACG Worldwide

22 Actylis

3 Aeon Procare

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

43 BASF

1 Bioplus Life Sciences

1 BioSpectra

5 CD Formulation

1 Clariant

17 Corel Pharma Chem

3 Doshion Polyscience

2 Esteem Industries

5 Finar

13 Gangwal Chemicals

3 Ideal Cures

2 Ingredion Pharma Solutions

INJECTABLE;INJECTION - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 20% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

JELLY;TOPICAL - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons